Another emerging area of PS biology that deserves further attention is whether tumor cells upregulate or alter the expression of Xkr8 or TMEM16F as a cell-intrinsic or driver event in host immune evasion and tumor progression. The gene discussed is XKR8; the disease is neoplasm.